🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT05110248
Recruiting Observational

Research and Development of Novel Quantitative Magnetic Resonance Imaging (MRI) Techniques in a Single Scan for Multiple Organ Application

NCT05110248 · tracked via the Priya Life Science UK tracker
Sponsor
Perspectum
Phase
Observational
Started
2021-11-15
Last updated
2026-05-20

Condition(s) studied

Multiple

Study summary

Cross-sectional observational study to improve MRI data acquisition techniques by optimising MRI sequences for multiple organs and assessing the repeatability and reproducibility of multiparametric MRI, in healthy volunteers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged 18 years and older * Participant is willing and able to give informed consent for participation in the study * The participant has a level of English proficiency that allows them to communicate well with the investigator and could comply with study requirements. * The participant is willing and able to undergo MRI scan. Exclusion Criteria: * Any contraindication to magnetic resonance imaging (incl. pregnancy, nonremovable electronic implants including cochlear implants, infusion pumps, and pacemakers, shrapnel injury, severe claustrophobia, allergic reaction to contrast agents) * Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study * The participant may be excluded where body habitus is likely to make MRI or echocardiography/ultrasound uncomfortable or unlikely to yield analysable images, and BMI more than 40-45

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Gemini One, 5520 John Smith Drive Oxford Oxfordshire Recruiting

More Perspectum trials in the UK

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05110248 on ClinicalTrials.gov ↗ ← All trials in the UK